For citations:

Kolyadina I.V., Poddubnaya I.V. ESR1 mutation as potential predictive marker for choice of treatment tactics in hormone-resistant HR+/HER2-negative breast cancer. Medical alphabet. 2020;(29):68-73. https://doi.org/10.33667/2078-5631-2020-29-61-73